RSQ-004 - Assessment of therapeutic equivalence of levothyroxine sodium in pharmaceutical tablets in Lebanon via novel analytical techniques: Quantitative analysis, in vitro release and tablet mapping

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: RSQ-004
• By: ALBATHISH, Malak (Beirut Arab University, Lebanon)
• Co-author(s): Dr Malak Albathish (Beirut Arab University, Beirut, Lebanon)
  Professor Azza Gazy (Beirut Arab University, Beirut, Lebanon)
  Dr. Marwa Al Jamal (Beirut Arab University, Beirut, Lebanon)
  Dr. Alice Bejjani (Lebanese Atomic Energy Commission, Beirut, Lebanon)
  
• Abstract:

  Introduction: Levothyroxine sodium – classified as a narrow therapeutic index drug- is one of the most prescribed medications in the world, administered orally as a thyroid hormone replacement therapy in cases of hypothyroidism. However, from literature and clinical practice, its bioavailability has been questioned and drug recalls have been..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login